CorMedix CRMD Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about CorMedix's cash provided by (used in) financing activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CorMedix's cash provided by (used in) financing activity, including discontinued operation?
- CorMedix (CRMD) reported cash provided by (used in) financing activity, including discontinued operation of -$12.1M in Q1 2026.
- How has CorMedix's cash provided by (used in) financing activity, including discontinued operation changed year-over-year?
- CorMedix's cash provided by (used in) financing activity, including discontinued operation decreased by 298.5% year-over-year, from $6.09M to -$12.1M.
- What is the long-term trend for CorMedix's cash provided by (used in) financing activity, including discontinued operation?
- Over 3 years (2022 to 2025), CorMedix's cash provided by (used in) financing activity, including discontinued operation has grown at a 137.5% compound annual growth rate (CAGR), from $17.9M to $239.87M.
- What does cash provided by (used in) financing activity, including discontinued operation mean?
- This metric measures the net cash flow between the company and its capital providers, including proceeds from debt or equity issuance and payments for dividends or share repurchases. It highlights how the company finances its operations and returns value to shareholders.